Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report.
Jibing Chen, Feng Mu, Tianyu Lu, Duanming Du, Kecheng Xu · OncoTargets and therapy · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In These data show that, after standard treatments had failed, hydrogen-gas monotherapy elicited significant effective control of tumors (especially those in the brain), and survival time was lengthened, brain metastasis of NSCLC cells is closely related to various signaling pathways, several of which involve the participation of hydrogen gas. These findings add human evidence that helps define the outcomes that did and did not change with molecular hydrogen in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in These data show that, after standard treatments had failed, hydrogen-gas monotherapy elicited significant effective control of tumors (especially those in the brain), and survival time was lengthened. Brain metastasis of NSCLC cells is closely related to various signaling pathways, several of which involve the participation of hydrogen gas.
What the Researchers Studied
The researchers studied These data show that, after standard treatments had failed, hydrogen-gas monotherapy elicited significant effective control of tumors (especially those in the brain), and survival time was lengthened. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Brain metastasis of NSCLC cells is closely related to various signaling pathways, several of which involve the participation of hydrogen gas. Lin et al 11 were the first (in 2016) to demonstrate that hydrogen gas suppresses abnormal activation of Wnt/β-catenin signaling. In 2019, Guan et al 14 reported that hydrogen gas can ameliorate chronic intermittent hypoxia-induced kidney injury by inhibiting oxidative stress-dependent activation of p38 and c-Jun N-terminal kinase (JNK).
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence. The research population or model was These data show that, after standard treatments had failed, hydrogen-gas monotherapy elicited significant effective control of tumors (especially those in the brain), and survival time was lengthened.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.